OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Persistence of suicidal ideation within acute phase treatment of major depressive disorder: analysis of clinical predictors
Paolo Olgiati, Alessandro Serretti
International Clinical Psychopharmacology (2022) Vol. 37, Iss. 5, pp. 193-200
Open Access | Times Cited: 14
Paolo Olgiati, Alessandro Serretti
International Clinical Psychopharmacology (2022) Vol. 37, Iss. 5, pp. 193-200
Open Access | Times Cited: 14
Showing 14 citing articles:
Anhedonia and Depressive Disorders
Alessandro Serretti
Clinical Psychopharmacology and Neuroscience (2023) Vol. 21, Iss. 3, pp. 401-409
Open Access | Times Cited: 53
Alessandro Serretti
Clinical Psychopharmacology and Neuroscience (2023) Vol. 21, Iss. 3, pp. 401-409
Open Access | Times Cited: 53
Suicide ideation and male-female differences in major depressive disorder
Paolo Olgiati, Basilio Pecorino, Alessandro Serretti
International Journal of Psychiatry in Clinical Practice (2024) Vol. 28, Iss. 1, pp. 53-62
Closed Access | Times Cited: 7
Paolo Olgiati, Basilio Pecorino, Alessandro Serretti
International Journal of Psychiatry in Clinical Practice (2024) Vol. 28, Iss. 1, pp. 53-62
Closed Access | Times Cited: 7
Clinical experiences with intranasal esketamine for major depressive disorder resistant to treatment and with a psychiatric emergency: case presentations
Maurizio Pompili, Giuseppe Sarli, Denise Erbuto, et al.
International Clinical Psychopharmacology (2023)
Closed Access | Times Cited: 10
Maurizio Pompili, Giuseppe Sarli, Denise Erbuto, et al.
International Clinical Psychopharmacology (2023)
Closed Access | Times Cited: 10
Clinical correlates and prognostic implications of severe suicidal ideation in major depressive disorder
Paolo Olgiati, Giuseppe Fanelli, Alessandro Serretti
International Clinical Psychopharmacology (2023) Vol. 38, Iss. 4, pp. 201-208
Open Access | Times Cited: 8
Paolo Olgiati, Giuseppe Fanelli, Alessandro Serretti
International Clinical Psychopharmacology (2023) Vol. 38, Iss. 4, pp. 201-208
Open Access | Times Cited: 8
A Critical View on New and Future Antidepressants
Alessandro Serretti
Clinical Psychopharmacology and Neuroscience (2024) Vol. 22, Iss. 2, pp. 201-210
Open Access | Times Cited: 2
Alessandro Serretti
Clinical Psychopharmacology and Neuroscience (2024) Vol. 22, Iss. 2, pp. 201-210
Open Access | Times Cited: 2
Hypomanic symptoms in major depressive disorder: Prognostic impact and treatment issues
Paolo Olgiati, Siegfried Kasper, Joseph Zohar, et al.
Journal of Affective Disorders (2024)
Closed Access | Times Cited: 2
Paolo Olgiati, Siegfried Kasper, Joseph Zohar, et al.
Journal of Affective Disorders (2024)
Closed Access | Times Cited: 2
The revival of psilocybin between scientific excitement, evidence of efficacy, and real-world challenges
Mauro Scala, Chiara Fabbri, Paolo Fusar‐Poli, et al.
CNS Spectrums (2024), pp. 1-15
Closed Access | Times Cited: 2
Mauro Scala, Chiara Fabbri, Paolo Fusar‐Poli, et al.
CNS Spectrums (2024), pp. 1-15
Closed Access | Times Cited: 2
Persistent suicidal ideation in major depressive disorder patients: still in need of empathic understanding
Maurizio Pompili
International Clinical Psychopharmacology (2022)
Closed Access | Times Cited: 11
Maurizio Pompili
International Clinical Psychopharmacology (2022)
Closed Access | Times Cited: 11
Advances in the treatment of depression
Alessandro Serretti
International Clinical Psychopharmacology (2022) Vol. 37, Iss. 5, pp. 183-184
Closed Access | Times Cited: 8
Alessandro Serretti
International Clinical Psychopharmacology (2022) Vol. 37, Iss. 5, pp. 183-184
Closed Access | Times Cited: 8
The pharmacological management of treatment-resistant depression: what does the future hold?
Alessandro Serretti
Expert Opinion on Pharmacotherapy (2023) Vol. 24, Iss. 18, pp. 1923-1925
Open Access | Times Cited: 3
Alessandro Serretti
Expert Opinion on Pharmacotherapy (2023) Vol. 24, Iss. 18, pp. 1923-1925
Open Access | Times Cited: 3
Molecular Changes Associated with Suicide
Daniela Navarro, Marta Marín-Mayor, Ani Gasparyan, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 23, pp. 16726-16726
Open Access | Times Cited: 3
Daniela Navarro, Marta Marín-Mayor, Ani Gasparyan, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 23, pp. 16726-16726
Open Access | Times Cited: 3
In search of clinical targets for suicide prevention in major depressive disorder
Paolo Olgiati, Alessandro Serretti
International Clinical Psychopharmacology (2023) Vol. 38, Iss. 3, pp. 184-186
Closed Access | Times Cited: 2
Paolo Olgiati, Alessandro Serretti
International Clinical Psychopharmacology (2023) Vol. 38, Iss. 3, pp. 184-186
Closed Access | Times Cited: 2
Neurological, Metabolic, and Psychopathological Correlates of Lifetime Suicidal Behaviour in Major Depressive Disorder without Current Suicide Ideation
Paolo Olgiati, Basilio Pecorino, Alessandro Serretti
Neuropsychobiology (2024) Vol. 83, Iss. 2, pp. 89-100
Closed Access
Paolo Olgiati, Basilio Pecorino, Alessandro Serretti
Neuropsychobiology (2024) Vol. 83, Iss. 2, pp. 89-100
Closed Access
The challenge of managing difficult to treat psychiatric conditions
Alessandro Serretti
International Clinical Psychopharmacology (2023) Vol. 38, Iss. 2, pp. 69-72
Closed Access
Alessandro Serretti
International Clinical Psychopharmacology (2023) Vol. 38, Iss. 2, pp. 69-72
Closed Access
